Daewoong Pharmaceutical announced that it will actively cooperate in applying AI digital healthcare solutions tailored to the needs of medical sites in three key areas: ▲enhancing patient safety, ▲improving diagnostic accuracy, and ▲streamlining clinical operations, in line with the Ministry of Health and Welfare's policy to support the introduction of AI clinical systems at regional responsible medical institutions.


Daewoong Pharmaceutical has been pursuing a "full-cycle healthcare" strategy that goes beyond medication-centered treatment by connecting health data generated in hospitals and daily life to enable disease prediction, prevention, diagnosis, treatment, and follow-up care. In particular, the company is building a "24-hour nationwide monitoring system" to enhance patient safety and create a seamless digital healthcare ecosystem that connects early detection and follow-up care without gaps.

Seoul Gangnam-gu Daewoong Pharmaceutical Headquarters building. Daewoong Pharmaceutical

Seoul Gangnam-gu Daewoong Pharmaceutical Headquarters building. Daewoong Pharmaceutical

View original image

Lee Changjae, CEO of Daewoong Pharmaceutical, stated, "Daewoong Pharmaceutical is advancing full-cycle healthcare by securing digital healthcare solutions that meet the three criteria set by the government, covering everything from diagnosis and prevention to follow-up care," adding, "We will expand our collaboration as an on-site partner, from the review of adoption by medical institutions to operation."


Daewoong Pharmaceutical is gradually expanding solutions that can be utilized at hospitals, screening centers, and in daily life in accordance with the government's three key directions. In the area of patient safety, the company is promoting bed monitoring systems that help medical staff immediately respond by detecting abnormal signs in inpatients at an early stage. For diagnostic accuracy, it is establishing a system that connects AI-based electrocardiogram analysis for screening risk signals to additional testing and treatment. In the area of clinical efficiency, it is building an environment that increases clinical focus by automating voice recording for medical staff.


Daewoong Pharmaceutical is enhancing patient safety and improving diagnostic accuracy, such as early detection of cardiovascular diseases, by integrating the AI-based smart bed monitoring system "THINK" with wearable devices like "CartBP" and "MobiCare."



In addition, the company is significantly improving on-site clinical efficiency by automating medical and nursing record work through "GenNote" and "VoiceENR," which recognize and record medical staff's speech in real time.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing